Article: Study shows Zadaxin improves immune system's detection of cancer cells.(Brief Article)

2002 OCT 22 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals, Inc., (SCLN) reported that treating colorectal cancer cells with Zadaxin significantly increases the expression of a detectable antigen that can be used by the body's immune system to target cancer cells for destruction.

This new study was presented in Boston at the 30th meeting of the International Society for Oncodevelopmental Biology and Medicine by Dr. Guido Rasi of the University Tor Vergata in Rome Italy. An in vitro study examined the expression of a colorectal cancer-specific protein, called TLP, on human cancer cells after treatment with Zadaxin. The percent of cancer cells in culture ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!